Evidence map›Paper›PMID 36810131›Full record

ArticleeLife2023

Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes.

Amanda R Dicks, Grigory I Maksaev, Zainab Harissa, Alireza Savadipour, Ruhang Tang, Nancy Steward, Wolfgang Liedtke, Colin G Nichols, Chia-Lung Wu, Farshid Guilak

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Bioactive materials · 2026
    Article
  3. A novel mutation inJCEM case reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Amanda R DicksDepartment of Biomedical Engineering, Washington University in St. Louis, St Louis, United States.ORCID 0000-0002-6036-280X
Grigory I MaksaevDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, St Louis, United States.
Zainab HarissaDepartment of Biomedical Engineering, Washington University in St. Louis, St Louis, United States.
Alireza SavadipourDepartment of Orthopedic Surgery, Washington University School of Medicine, St. Louis, St Louis, United States.
Ruhang TangDepartment of Orthopedic Surgery, Washington University School of Medicine, St. Louis, St Louis, United States.
Nancy StewardDepartment of Orthopedic Surgery, Washington University School of Medicine, St. Louis, St Louis, United States.
Wolfgang LiedtkeDepartment of Neurology, Duke University School of Medicine, Durham, United States.
Colin G NicholsDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, St Louis, United States.ORCID 0000-0002-4929-2134
Chia-Lung WuDepartment of Orthopaedics and Rehabilitation, Center for Musculoskeletal Research, University of Rochester, Rochester, United States.ORCID 0000-0001-9598-7036
Farshid GuilakDepartment of Orthopedic Surgery, Washington University School of Medicine, St. Louis, St Louis, United States.ORCID 0000-0001-7380-0330
Washington University in St. Louis · USDuke University · USUniversity of Rochester · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
VISCOELASTIC PROPERTIES OF NORMAL AND OA CHONDRONSR01AG015768 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 1998 to 2022
$7.7M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Deborah J Lenschow, Christine T. Pham · 2018 to 2026
$7.6M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
Role of vascular KATP channels in Alzheimer’s neurodegeneration and dementiaR35HL140024 · NHLBI · WASHINGTON UNIVERSITY · PI NICHOLS, COLIN G · 2018 to 2023
$5.9M
OBESITY, BIOMECHANICS, AND INFLAMMATION IN OSTEOARTHRITISR01AG046927 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2013 to 2023
$3.2M
Deconstructing Cartilage Mechanotransduction by Piezo ChannelsR01AR072999 · NIAMS · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2020 to 2024
$2.9M
Imaging, Modeling and Engineering of Diabetic TissuesT32DK108742 · NIDDK · WASHINGTON UNIVERSITY · PI NICHOLS, COLIN G · 2016 to 2020
$1.4M
Epigenetic Regulation of Chondrogenesis and Cartilage DevelopmentR00AR075899 · NIAMS · UNIVERSITY OF ROCHESTER · PI WU, CHIA-LUNG · 2021 to 2023
$1.1M
INTERDISCIPLINARY TRAINING IN MECHANOBIOLOGY FROM NM TO CMT32EB018266 · NIBIB · WASHINGTON UNIVERSITY · PI BAYLY, PHILIP V · 2014 to 2018
$987k
Epigenetic Regulation of Chondrogenesis and Cartilage DevelopmentK99AR075899 · NIAMS · WASHINGTON UNIVERSITY · PI WU, CHIA-LUNG · 2019 to 2020
$180k
NCATS NIH HHS UL1 TR002345NHLBI NIH HHS R35 HL140024NIAMS NIH HHS K99 AR075899NIAMS NIH HHS P30 AR073752NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R00 AR075899NIAMS NIH HHS R01 AR072999NIA NIH HHS R01 AG015768NIA NIH HHS R01 AG046927NIBIB NIH HHS T32 EB018266NIDDK NIH HHS T32 DK108742
6 · The paper itself

Abstract

Mutations in the TRPV4 ion channel can lead to a range of skeletal dysplasias. However, the mechanisms by which TRPV4 mutations lead to distinct disease severity remain unknown. Here, we use CRISPR-Cas9-edited human-induced pluripotent stem cells (hiPSCs) harboring either the mild V620I or lethal T89I mutations to elucidate the differential effects on channel function and chondrogenic differentiation. We found that hiPSC-derived chondrocytes with the V620I mutation exhibited increased basal currents through TRPV4. However, both mutations showed more rapid calcium signaling with a reduced overall magnitude in response to TRPV4 agonist GSK1016790A compared to wildtype (WT). There were no differences in overall cartilaginous matrix production, but the V620I mutation resulted in reduced mechanical properties of cartilage matrix later in chondrogenesis. mRNA sequencing revealed that both mutations up-regulated several anterior

Indexed as

Induced Pluripotent Stem CellsOsteochondrodysplasiasCell DifferentiationChondrocytesChondrogenesisHumansHypertrophyMutationTRPV Cation ChannelsTRPV4 protein, humanTRPV Cation ChannelsbonecartilagechondrocytedysplasiahumaniPSCpluripotent stem cellregenerative medicinestem cellsTRPV4

Identifiers

PMID36810131
PMCPMC9949800
OpenAlexW4321495918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.